MedPath

Comparative study of efficacy 4 lasers: PDL, QSwitch-Nd-YAG, CO2 and CO2+Qswitch-Nd-YAG in treatment of cutaneous macular amyloidosis

Phase 4
Recruiting
Conditions
cutaneous macular amyloidosis.
Amyloidosis of skin
Registration Number
IRCT20181217042026N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

All patients with cutaneous macular amyloidosis referred to Dermatology Clinic of Ahvaz Imam Khomeini Hospital

Exclusion Criteria

history of allergy due to laser therapy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
lcer improvement. Timepoint: after laser therapy and 4 months after that. Method of measurement: observation of ulcer area.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath